PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Effects of the dimeric PSD-95 inhibitor UCCB01-144 on functional recovery after fimbria-fornix transection in rats.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28943199 ↗2017No effect reported

Effects of the dimeric PSD-95 inhibitor UCCB01-144 on functional recovery after fimbria-fornix transection in rats.

RatTBIUnspecifiedWistarMaleIntravenous, lateral tail vein injectionImmediately after fimbria-fornix transection or sham surgery

Model: Fimbria-fornix transection, an experimental traumatic brain injury model

Task acquisition was significantly impaired in fimbria-fornix transected animals, but UCCB01-144 had no significant effect on spatial delayed alternation after transection or sham surgery, although decelerated learning curves were seen after treatment in transected animals.

Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.